Corporate Finance

With its largest fund yet, the firm is doubling down on breakthrough biotech and medtech, signaling strong investor faith in deep science innovation.

With a massive new investment, CyberFOX plans to accelerate AI development and acquisitions, aiming to reshape the security landscape for underserved MSPs.

SunPower secures a $20M backstop funding deal, part of a complex strategy to escape financial distress and achieve profitability by late 2026.

Offshore driller Foresea doubles its cash offer to amend debt rules, seeking flexibility for $175M in payments, a move that alters its risk profile.

The analytics giant pays down debt and buys back stock, signaling financial health, but faces analyst skepticism over its long-term growth strategy.

With over 9 million shares repurchased, Aimia doubles down on its strategy to fix its stock's undervaluation. Is it a sustainable fix or financial engineering?

Amid strategic uncertainty after a rejected takeover, STAAR Surgical appoints two veteran executives as interim co-CEOs while launching a global search.

A new FinTech giant is born. Teciem spins out of Finastra with Apax backing, a $2B valuation, and a plan to innovate for the world's top banks.

Flowco's steady dividend signals financial health in a volatile sector, but its strategic focus on methane abatement technology is the real growth story.

The long-duration energy storage firm closed a key offering, signaling investor confidence in its iron flow technology despite a challenging year for its stock.

DBM Global’s $5 million dividend highlights its financial resilience and key role in parent INNOVATE Corp’s strategy, boosting investor confidence.

Shane Kovacs's exit from Olema Oncology introduces leadership questions as the biotech firm nears a pivotal data readout for its lead breast cancer drug.

Tevogen Bio's stock surged on news of a potential special dividend, but a closer look reveals a risky promise from a pre-revenue firm facing major hurdles.

The CFP Board disciplined nine individuals, revoking certifications for roles in a Ponzi scheme and fraud, reinforcing its role as an ethical watchdog.

A landmark deal revives a Greek arms factory, creating hundreds of jobs and aiming to solve Europe's critical ammunition shortage amid rising tensions.

RedBird Capital Partners cements its control over AC Milan with a major refinancing deal, clearing debt to Elliott and paving the way for a new stadium.

The Non-GMO Project's grant program helps BIPOC food entrepreneurs overcome barriers, gain market access, and reshape the natural products industry.

Digital entertainment firm GigaMedia adds a legal and finance expert to its board, fueling speculation about future M&A in a competitive gaming market.

With a major cash infusion, NeOnc Technologies is set to accelerate its promising therapies aimed at conquering the elusive blood-brain barrier.

Disney hires top Morgan Stanley analyst Benjamin Swinburne, signaling a strategic pivot to embed Wall Street's perspective directly into its core leadership.